The research Every test, including the kills

00 / The research

How we got here.

Most ideas die. We publish them anyway, including the ones that did.

Every factor we tested, across crypto and US equities, with its real net-of-cost Sharpe and what we did with it. Two survived. Most we killed.

-- factors tested -- survived -- killed across -- families forward -- Sharpe grade --

Scroll

01 / Factor tests

Every test, its real Sharpe, and its real Rank-IC.

Every test we ran, with its net-of-cost Sharpe and Rank-IC.

// Rank-IC is the cross-sectional information coefficient with a Newey-West t-stat. Net Sharpe is the purged walk-forward result after the cost model. Select a row for its full performance, its Rank-IC by horizon, and the source artifact.

Filter
Factor Family Net Sharpe Rank-IC (t) Verdict

02 / What survived

Two sleeves survived. Real, decorrelated, and honestly modest.

Two standalone algorithms: AlphaForge in crypto funding carry, AlphaMax in US equity momentum. They barely correlate. Combined at equal risk, they form ALPHAC, the cross-asset book.

-- Full-sample correlation
-- On equity down-days
-- Stress union

--

In-sample, research window

NOT the forward expectation

--

Sharpe
--
CAGR
--
Max DD
--

Honest forward expectation

After multiple-testing deflation
Sharpe
--
Return (vol-targeted)
--
Worst DD
--

--

Combined-book deflation

Combined DSR (N=69)
--
Combined DSR (N=518)
--
DSR gate
--
Standalone equity DSR
--
Standalone crypto DSR
--

--

-- Honest grade

--

  • Equity capacity --
  • Crypto carry capacity --
  • BTC-correlation cap --
  • Equity survivors --

03 / Methodology

The data layer blocks leaks at the source, not after the fact.

The validation method in plain language: point-in-time data, purged walk-forward, deflation gates, pre-registration, and a byte-reproducible backtest.

04 / Crypto alone

Crypto alone is a null net of cost. Here is the proof.

Before the equity ballast, we ran crypto perpetuals through the deflation gates on their own. The result is NO-DEPLOY. The edge is too thin to survive cost.

-- -- -- trials best config --

Deflated Sharpe (shared) --
-- gate --
Prob. of backtest overfitting --
-- gate < --

Capacity decay, annualised Sharpe by deployed capital

--

--

--

05 / Roadmap

The binding constraint is sample length, not idea count.

The free-breadth path is exhausted. From here, two steps.

// --

This export

Schema
--
Generated
--
Content hash
--

// --